MedTrace Logo

Comprehensive Prospective Comparison Of Two Robotic Platforms In Anatomical Lung Resections: Clinical Outcomes And Cost-utility Analysis

NCT07537556 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2026-04-17

No results posted yet for this study

Summary

The goal is to compare clinical outcomes, hospital costs, and cost-utility in patients undergoing anatomical lung resections with DaVinci Xi vs Versius platforms

The main questions it aims to answer are:

* Do patients that undergo an anatomical lung resection with DaVinci Xi have the same clinical outcomes (complications, stay...) than those who were operated with Versius?
* Are anatomical lung resections performed with DaVinci Xi more expensive than those performed with Versius?
* Are anatomical lung resection performed with DaVinci Xi more cost-effective than those performed with Versius?

Participants already undergoing robotic anatomical lung resection as part of their regular medical care will answer quality of life questionnaires preoperatively, at 1, 3, 6, and 12 months after surgery.

Conditions

  • Pulmonary Nodule, Solitary
  • Lung Cancer (NSCLC)
  • Pulmonary Metastases

Interventions

DEVICE

da Vinci Xi Surgical System

Robotic platform used to perform anatomical lung resection (lobectomy or segmentectomy)

DEVICE

Versius Surgical System

Robotic platform used to perform anatomical lung resection (lobectomy or segmentectomy)

Sponsors & Collaborators

  • Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2026-07-31
Completion
2026-07-31
FDA Device
Yes

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07537556 on ClinicalTrials.gov